Recombinant multi-species TRIM13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRIM13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This gene is located on chromosome 13 within the minimal deletion region for B-cell chronic lymphocytic leukemia. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 3110001L12Rik,B-cell chronic lymphocytic leukemia tumor suppressor Leu5,CAR,DLEU5,E3 ubiquitin-protein ligase TRIM13,LEU5,Leukemia-associated protein 5,Putative tumor suppressor RFP2,RFP2,RING finger protein 77,RING-type E3 ubiquitin transferase TRIM13,RNF77,Ret finger protein 2,Rfp2,TRIM13,Trim13,Tripartite motif-containing protein 13

Target products collectionGo to TRIM13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2176-Ag-1/ GM-Tg-hg-IP2176-Ag-2 Human TRIM13 protein Human
GM-Tg-rg-IP2176-Ag-1/ GM-Tg-rg-IP2176-Ag-2 Rat TRIM13 protein Rat
GM-Tg-mg-IP2176-Ag-1/ GM-Tg-mg-IP2176-Ag-2 Mouse TRIM13 protein Mouse
GM-Tg-cynog-IP2176-Ag-1/ GM-Tg-cynog-IP2176-Ag-2 Cynomolgus/Rhesus macaque TRIM13 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2176-Ag-1/ GM-Tg-felg-IP2176-Ag-2 Feline TRIM13 protein Feline
GM-Tg-cang-IP2176-Ag-1/ GM-Tg-cang-IP2176-Ag-2 Canine TRIM13 protein Canine
GM-Tg-bovg-IP2176-Ag-1/ GM-Tg-bovg-IP2176-Ag-2 Bovine TRIM13 protein Bovine
GM-Tg-equg-IP2176-Ag-1/ GM-Tg-equg-IP2176-Ag-2 Equine TRIM13 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2176-Ag-1/ GM-Tg-hg-IP2176-Ag-2; GM-Tg-rg-IP2176-Ag-1/ GM-Tg-rg-IP2176-Ag-2;
GM-Tg-mg-IP2176-Ag-1/ GM-Tg-mg-IP2176-Ag-2; GM-Tg-cynog-IP2176-Ag-1/ GM-Tg-cynog-IP2176-Ag-2;
GM-Tg-felg-IP2176-Ag-1/ GM-Tg-felg-IP2176-Ag-2; GM-Tg-cang-IP2176-Ag-1/ GM-Tg-cang-IP2176-Ag-2;
GM-Tg-bovg-IP2176-Ag-1/ GM-Tg-bovg-IP2176-Ag-2; GM-Tg-equg-IP2176-Ag-1/ GM-Tg-equg-IP2176-Ag-2
Products Name TRIM13 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TRIM13
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRIM13 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.